{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:29:54Z","timestamp":1786116594053,"version":"build-2736575974"},"reference-count":116,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-74545-4","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T02:49:02Z","timestamp":1782182942000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["MiT fusions, TSC1\u2013TSC2 divergence, and stem-like programs reveal distinct origins and vulnerabilities in PEComa"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3293-4903","authenticated-orcid":false,"given":"Justine","family":"Gantzer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2417-6548","authenticated-orcid":false,"given":"Xiaofan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Charon-Barra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Vinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00eblle","family":"Weingertner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonin","family":"Fattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Pierre","family":"Chenard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8569-6163","authenticated-orcid":false,"given":"Damien","family":"Plassard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Vicaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8582-9819","authenticated-orcid":false,"given":"Fran\u00e7ois","family":"Le Loarer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maud","family":"Toulmonde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Karanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Brahmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine","family":"Ngo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Le Cesne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Hervieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena\u00efg","family":"Mescam-Mancini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0157-0959","authenticated-orcid":false,"given":"Fran\u00e7ois","family":"Bertucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Beaujot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Ryckewaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6238-1599","authenticated-orcid":false,"given":"Philippe","family":"Rochaix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibaud","family":"Valentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Macagno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Duffaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0840-9834","authenticated-orcid":false,"given":"Matthias","family":"Tallegas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Chetaille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Valo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Bompas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marick","family":"Lae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flore","family":"Delalande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Llamas-Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Rioux-Leclercq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7190-120X","authenticated-orcid":false,"given":"Jean-Yves","family":"Blay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Emmanuel","family":"Kurtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3527-0417","authenticated-orcid":false,"given":"Gabriel G.","family":"Malouf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"74545_CR1","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/00000478-199102000-00020","volume":"15","author":"M Pea","year":"1991","unstructured":"Pea, M. et al. Clear cell tumor and angiomyolipoma.  Am. J. Surg. Pathol. 15, 199\u2013202 (1991).","journal-title":"Am. J. Surg. Pathol."},{"key":"74545_CR2","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3109\/00313029109063563","volume":"23","author":"M Pea","year":"1991","unstructured":"Pea, M. et al. Melanocyte-marker-HMB-45 is regularly expressed in angiomyolipoma of the kidney. Pathology 23, 185\u2013188 (1991).","journal-title":"Pathology"},{"key":"74545_CR3","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1097\/00000478-199203000-00013","volume":"16","author":"F Bonetti","year":"1992","unstructured":"Bonetti, F., Pea, M., Martignoni, G. & Zamboni, G. PEC and sugar.  Am. J. Surg. Pathol. 16, 307\u2013308 (1992).","journal-title":"Am. J. Surg. Pathol."},{"key":"74545_CR4","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1080\/00313029400169561","volume":"26","author":"F Bonetti","year":"1994","unstructured":"Bonetti, F. et al. Clear cell (\u201csugar\u201d) tumor of the lung is a lesion strictly related to angiomyolipoma, the concept of a family of lesions characterized by the presence of the perivascular epithelioid cells (PEC). Pathology 26, 230\u2013236 (1994).","journal-title":"Pathology"},{"key":"74545_CR5","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1097\/00000478-199606000-00010","volume":"20","author":"G Zamboni","year":"1996","unstructured":"Zamboni, G. et al. Clear cell \u201csugar\u201d tumor of the pancreas. A novel member of the family of lesions characterized by the presence of perivascular epithelioid cells.  Am. J. Surg. Pathol. 20, 722\u2013730 (1996).","journal-title":"Am. J. Surg. Pathol."},{"key":"74545_CR6","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/modpathol.3880351","volume":"14","author":"F Bonetti","year":"2001","unstructured":"Bonetti, F. et al. Abdominopelvic sarcoma of perivascular epithelioid cells. Report of four cases in young women, one with tuberous sclerosis. Mod. Pathol. 14, 563\u2013568 (2001).","journal-title":"Mod. Pathol."},{"key":"74545_CR7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1477-7819-2-35","volume":"2","author":"O Fadare","year":"2004","unstructured":"Fadare, O. et al. Perivascular epithelioid cell tumor (PEComa) of the uterine cervix associated with intra-abdominal \u201cPEComatosis\u201d: a clinicopathological study with comparative genomic hybridization analysis. World J. Surg. Oncol. 2, 35 (2004).","journal-title":"World J. Surg. Oncol."},{"key":"74545_CR8","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/med4.70032","volume":"3","author":"Z Wu","year":"2025","unstructured":"Wu, Z., Su, Z., Huang, J., Gluchman, M. & Zhao, C. The burden and trends of soft tissue and extraosseous sarcomas in China: an observational study from 1990 to 2021. Med. Adv. 3, 145\u2013157 (2025).","journal-title":"Med. Adv."},{"key":"74545_CR9","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.1002\/cncr.33618","volume":"127","author":"S Stacchiotti","year":"2021","unstructured":"Stacchiotti, S. et al. Ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities. Cancer 127, 2934\u20132942 (2021).","journal-title":"Cancer"},{"key":"74545_CR10","doi-asserted-by":"publisher","first-page":"e0246958","DOI":"10.1371\/journal.pone.0246958","volume":"16","author":"G de Pinieux","year":"2021","unstructured":"de Pinieux, G. et al. Nationwide incidence of sarcomas and connective tissue tumors of intermediate malignancy over four years using an expert pathology review network. PLOS ONE 16, e0246958 (2021).","journal-title":"PLOS ONE"},{"key":"74545_CR11","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1097\/01.pas.0000173232.22117.37","volume":"29","author":"AL Folpe","year":"2005","unstructured":"Folpe, A. L. et al. Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the literature.  Am. J. Surg. Pathol. 29, 1558\u20131575 (2005).","journal-title":"Am. J. Surg. Pathol."},{"key":"74545_CR12","doi-asserted-by":"publisher","unstructured":"Bleeker, J. S., Quevedo, J. F. & Folpe, A. L. \u201cMalignant\u201d perivascular epithelioid cell neoplasm: risk stratification and treatment strategies. Sarcoma 2012, https:\/\/doi.org\/10.1155\/2012\/541626 (2012).","DOI":"10.1155\/2012\/541626"},{"key":"74545_CR13","doi-asserted-by":"publisher","first-page":"5227","DOI":"10.3390\/cancers13205227","volume":"13","author":"A Bourgmayer","year":"2021","unstructured":"Bourgmayer, A. et al. Natural history and treatment strategies of advanced pecomas: a systematic review. Cancers 13, 5227 (2021).","journal-title":"Cancers"},{"key":"74545_CR14","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1002\/cncr.35277","volume":"130","author":"J Gantzer","year":"2024","unstructured":"Gantzer, J. et al. PEC-PRO: a new prognostic score from a series of 87 patients with localized perivascular epithelioid cell neoplasms (PEComas) treated with curative intent. Cancer 130, 2304\u20132314 (2024).","journal-title":"Cancer"},{"key":"74545_CR15","doi-asserted-by":"publisher","first-page":"5295","DOI":"10.1158\/1078-0432.CCR-19-0288","volume":"25","author":"R Sanfilippo","year":"2019","unstructured":"Sanfilippo, R. et al. Role of chemotherapy, VEGFR inhibitors, and mTOR inhibitors in advanced perivascular epithelioid cell tumors (PEComas). Clin. Cancer Res. 25, 5295\u20135300 (2019).","journal-title":"Clin. Cancer Res."},{"key":"74545_CR16","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1097\/CCO.0000000000000649","volume":"32","author":"C Fabbroni","year":"2020","unstructured":"Fabbroni, C., Sbaraglia, M. & Sanfilippo, R. Medical treatment of advanced malignant perivascular epithelioid cell tumors. Curr. Opin. Oncol. 32, 301\u2013306 (2020).","journal-title":"Curr. Opin. Oncol."},{"key":"74545_CR17","doi-asserted-by":"publisher","first-page":"3660","DOI":"10.1200\/JCO.21.01728","volume":"39","author":"AJ Wagner","year":"2021","unstructured":"Wagner, A. J. et al. Nab-sirolimus for patients with malignant perivascular epithelioid cell tumors. J. Clin. Oncol. 39, 3660\u20133670 (2021).","journal-title":"J. Clin. Oncol."},{"key":"74545_CR18","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/j.annonc.2021.07.006","volume":"32","author":"A Gronchi","year":"2021","unstructured":"Gronchi, A. et al. Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up\u2729. Ann. Oncol. 32, 1348\u20131365 (2021).","journal-title":"Ann. Oncol."},{"key":"74545_CR19","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1097\/PAS.0000000000000389","volume":"39","author":"NP Agaram","year":"2015","unstructured":"Agaram, N. P. et al. Dichotomy of genetic abnormalities in PEComas with therapeutic implications.  Am. J. Surg. Pathol. 39, 813\u2013825 (2015).","journal-title":"Am. J. Surg. Pathol."},{"key":"74545_CR20","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1159\/000510241","volume":"98","author":"S Akumalla","year":"2020","unstructured":"Akumalla, S. et al. Characterization of clinical cases of malignant pecoma via comprehensive genomic profiling of DNA and RNA. Oncology 98, 905\u2013912 (2020).","journal-title":"Oncology"},{"key":"74545_CR21","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1097\/PAS.0000000000002028","volume":"47","author":"WJ Anderson","year":"2023","unstructured":"Anderson, W. J., Dong, F., Fletcher, C. D. M., Hirsch, M. S. & Nucci, M. R. A clinicopathologic and molecular characterization of uterine sarcomas classified as malignant PEComa.  Am. J. Surg. Pathol. 47, 535\u2013546 (2023).","journal-title":"Am. J. Surg. Pathol."},{"key":"74545_CR22","doi-asserted-by":"publisher","unstructured":"Gagnon, M.-F. et al. Molecular alterations in primary and metastatic PEComa: insights from the AACR Project GENIE Dataset. Hum. Pathol. https:\/\/doi.org\/10.1016\/j.humpath.2023.10.001 (2023).","DOI":"10.1016\/j.humpath.2023.10.001"},{"key":"74545_CR23","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1097\/PAS.0000000000002135","volume":"48","author":"A de la Fouchardiere","year":"2024","unstructured":"de la Fouchardiere, A. et al. Melanotic PEComa: a Rare But Distinctive Subtype Analyzed in a Series of 7 Cases.  Am. J. Surg. Pathol. 48, 88\u201396 (2024).","journal-title":"Am. J. Surg. Pathol."},{"key":"74545_CR24","doi-asserted-by":"publisher","unstructured":"Hanna, J. et al. PEComa with MITF overexpression: clinicopathologic and molecular analysis of a series of 36 cases. Am. J. Surg. Pathol. https:\/\/doi.org\/10.1097\/PAS.0000000000002276 (2024).","DOI":"10.1097\/PAS.0000000000002276"},{"key":"74545_CR25","doi-asserted-by":"publisher","first-page":"11539","DOI":"10.1200\/JCO.2021.39.15_suppl.11539","volume":"39","author":"A Seeber","year":"2021","unstructured":"Seeber, A. et al. Deciphering the molecular landscape and the tumor microenvironment of perivascular epitheloid cell neoplasma (PEComa). J. Clin. Oncol. 39, 11539\u201311539 (2021).","journal-title":"J. Clin. Oncol."},{"key":"74545_CR26","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/ajcp\/aqac152","volume":"159","author":"R Rammal","year":"2023","unstructured":"Rammal, R., Korentzelos, D., Skaugen, J. M. & Quiroga-Garza, G. M. Molecular characterization of malignant renal epithelioid angiomyolipoma: a review of two cases. Am. J. Clin. Pathol. 159, 211\u2013220 (2023).","journal-title":"Am. J. Clin. Pathol."},{"key":"74545_CR27","doi-asserted-by":"publisher","unstructured":"Wagner, A. J. et al. Phase II trial of nab-sirolimus in patients with advanced malignant perivascular epithelioid cell tumors (AMPECT): long-term efficacy and safety update. J. Clin. Oncol. https:\/\/doi.org\/10.1200\/JCO.23.02266 (2024).","DOI":"10.1200\/JCO.23.02266"},{"key":"74545_CR28","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nature12113","volume":"497","author":"C Kandoth","year":"2013","unstructured":"Kandoth, C. et al. Integrated genomic characterization of endometrial carcinoma. Nature 497, 67\u201373 (2013).","journal-title":"Nature"},{"key":"74545_CR29","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1038\/s41416-023-02203-3","volume":"128","author":"Y Asami","year":"2023","unstructured":"Asami, Y. et al. Utility of molecular subtypes and genetic alterations for evaluating clinical outcomes in 1029 patients with endometrial cancer. Br. J. Cancer 128, 1582\u20131591 (2023).","journal-title":"Br. J. Cancer"},{"key":"74545_CR30","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou, C. M. et al. Molecular portraits of human breast tumours. Nature 406, 747\u2013752 (2000).","journal-title":"Nature"},{"key":"74545_CR31","doi-asserted-by":"publisher","first-page":"6011","DOI":"10.1158\/0008-5472.CAN-18-0502","volume":"78","author":"MM Gaudet","year":"2018","unstructured":"Gaudet, M. M. et al. Pooled analysis of nine cohorts reveals breast cancer risk factors by tumor molecular subtype. Cancer Res. 78, 6011\u20136021 (2018).","journal-title":"Cancer Res."},{"key":"74545_CR32","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/path.6347","volume":"264","author":"S Mitra","year":"2024","unstructured":"Mitra, S. et al. Transcriptomic profiles of myxofibrosarcoma and undifferentiated pleomorphic sarcoma correlate with clinical and genomic features.  J. Pathol. 264, 293\u2013304 (2024).","journal-title":"J. Pathol."},{"key":"74545_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202404510","volume":"11","author":"Y Chen","year":"2024","unstructured":"Chen, Y. et al. Molecular profiling defines three subtypes of synovial sarcoma. Adv. Sci. 11, 2404510 (2024).","journal-title":"Adv. Sci."},{"key":"74545_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2024.104097","volume":"10","author":"C Park","year":"2025","unstructured":"Park, C. et al. Genomic profiling of intimal sarcoma reveals molecular subtypes with distinct tumor microenvironments and therapeutic implications. ESMO open 10, 104097 (2025).","journal-title":"ESMO open"},{"key":"74545_CR35","first-page":"311","volume":"37","author":"S Wei","year":"2022","unstructured":"Wei, S., Testa, J. R. & Argani, P. A review of neoplasms with MITF\/MiT family translocations. Histol. Histopathol. 37, 311\u2013321 (2022).","journal-title":"Histol. Histopathol."},{"key":"74545_CR36","doi-asserted-by":"publisher","unstructured":"Argani, P. et al. TFE3-rearranged PEComa\/PEComa-like neoplasms: report of 25 new cases expanding the clinicopathologic spectrum and highlighting its association with prior exposure to chemotherapy. Am. J. Surg. Pathol. https:\/\/doi.org\/10.1097\/PAS.0000000000002218 (2024).","DOI":"10.1097\/PAS.0000000000002218"},{"key":"74545_CR37","doi-asserted-by":"publisher","unstructured":"Agaimy, A. et al. TFE3-rearranged Head and Neck Neoplasms: Twenty-two Cases Spanning the Morphologic Continuum Between Alveolar Soft Part Sarcoma and PEComa and Highlighting Genotypic Diversity. The American Journal of Surgical Pathology, 10.1097\/PAS.0000000000002334, https:\/\/doi.org\/10.1097\/pas.0000000000002334 (9900).","DOI":"10.1097\/pas.0000000000002334"},{"key":"74545_CR38","doi-asserted-by":"publisher","unstructured":"Gagnon, M. F. et al. Molecular alterations in primary and metastatic pecoma: insights from the AACR project GENIE dataset. Human pathol. https:\/\/doi.org\/10.1016\/j.humpath.2023.10.001 (2023).","DOI":"10.1016\/j.humpath.2023.10.001"},{"key":"74545_CR39","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.21873\/anticanres.17227","volume":"44","author":"H Lee","year":"2024","unstructured":"Lee, H., Cho, Y. A., Kim, D. G., Son, J. Y. & Cho, E. Y. Real-world comparison of P53 immunohistochemistry and TP53 mutation analysis using next-generation sequencing. Anticancer Res. 44, 3983\u20133994 (2024).","journal-title":"Anticancer Res."},{"key":"74545_CR40","doi-asserted-by":"publisher","first-page":"378","DOI":"10.4132\/jptm.2020.06.01","volume":"54","author":"HJ Hwang","year":"2020","unstructured":"Hwang, H. J. et al. Prediction of TP53 mutations by p53 immunohistochemistry and their prognostic significance in gastric cancer. J. Pathol. Transl. Med. 54, 378\u2013386 (2020).","journal-title":"J. Pathol. Transl. Med."},{"key":"74545_CR41","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.pathol.2025.05.007","volume":"57","author":"T Kim","year":"2025","unstructured":"Kim, T. et al. Linking p53 immunostaining to TP53 mutation status in patients with non-small cell lung cancer. Pathology 57, 881\u2013889 (2025).","journal-title":"Pathology"},{"key":"74545_CR42","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41379-021-00855-1","volume":"35","author":"JA Bennett","year":"2022","unstructured":"Bennett, J. A. et al. Uterine PEComas: correlation between melanocytic marker expression and TSC alterations\/TFE3 fusions. Mod. Pathol. 35, 515\u2013523 (2022).","journal-title":"Mod. Pathol."},{"key":"74545_CR43","doi-asserted-by":"publisher","first-page":"817","DOI":"10.5858\/arpa.2022-0127-OA","volume":"147","author":"MR McCarthy","year":"2023","unstructured":"McCarthy, M. R. et al. Molecular and immunophenotypic correlates of metastatic epithelioid angiomyolipoma include alterations of TP53, RB1, and ATRX. Arch. Pathol. Lab. Med. 147, 817\u2013825 (2023).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"74545_CR44","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/PAS.0000000000001572","volume":"45","author":"P Selenica","year":"2021","unstructured":"Selenica, P. et al. Genomic profiling aids classification of diagnostically challenging uterine mesenchymal tumors with myomelanocytic differentiation.  Am. J. Surg. Pathol. 45, 77\u201392 (2021).","journal-title":"Am. J. Surg. Pathol."},{"key":"74545_CR45","doi-asserted-by":"publisher","unstructured":"Michal, M., Billings, S. D. & Brenn, T. MITF pathway-activated cutaneous neoplasms. Adv. Anat. Patho. https:\/\/doi.org\/10.1097\/pap.0000000000000496 (2025).","DOI":"10.1097\/pap.0000000000000496"},{"key":"74545_CR46","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1097\/PAS.0000000000001630","volume":"45","author":"A de la Fouchardiere","year":"2021","unstructured":"de la Fouchardiere, A. et al. Clear cell tumor with melanocytic differentiation and ACTIN-MITF translocation: report of 7 cases of a novel entity.  Am. J. Surg. Pathol. 45, 962\u2013968 (2021).","journal-title":"Am. J. Surg. Pathol."},{"key":"74545_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-58678-6","volume":"16","author":"A Soupir","year":"2025","unstructured":"Soupir, A. et al. Genomic, transcriptomic, and immunogenomic landscape of over 1300 sarcomas of diverse histology subtypes. Nat. Commun. 16, 4206 (2025).","journal-title":"Nat. Commun."},{"key":"74545_CR48","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/nm.2174","volume":"16","author":"F Chibon","year":"2010","unstructured":"Chibon, F. et al. Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity. Nat. Med. 16, 781\u2013787 (2010).","journal-title":"Nat. Med."},{"key":"74545_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-1070-5","volume":"17","author":"E Becht","year":"2016","unstructured":"Becht, E. et al. Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol. 17, 218 (2016).","journal-title":"Genome Biol."},{"key":"74545_CR50","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41586-019-1906-8","volume":"577","author":"F Petitprez","year":"2020","unstructured":"Petitprez, F. et al. B cells are associated with survival and immunotherapy response in sarcoma. Nature 577, 556\u2013560 (2020).","journal-title":"Nature"},{"key":"74545_CR51","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.ccell.2023.03.010","volume":"41","author":"KM Campbell","year":"2023","unstructured":"Campbell, K. M. et al. Prior anti-CTLA-4 therapy impacts molecular characteristics associated with anti-PD-1 response in advanced melanoma. Cancer cell 41, 791\u2013806.e794 (2023).","journal-title":"Cancer cell"},{"key":"74545_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101287","volume":"4","author":"X Lu","year":"2023","unstructured":"Lu, X. et al. Silencing of genes by promoter hypermethylation shapes tumor microenvironment and resistance to immunotherapy in clear-cell renal cell carcinomas. Cell Rep. Med. 4, 101287 (2023).","journal-title":"Cell Rep. Med."},{"key":"74545_CR53","doi-asserted-by":"publisher","unstructured":"Lu, X. et al. An enhancer demethylator phenotype converged to immune dysfunction and resistance to immune checkpoint inhibitors in clear-cell renal cell carcinomas. Clin. Cancer Res. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-22-2133 (2022).","DOI":"10.1158\/1078-0432.Ccr-22-2133"},{"key":"74545_CR54","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/path.5470","volume":"251","author":"X-T Wang","year":"2020","unstructured":"Wang, X.-T. et al. Malignant melanotic Xp11 neoplasms exhibit a clinicopathologic spectrum and gene expression profiling akin to alveolar soft part sarcoma: a proposal for reclassification. J. Pathol. 251, 365\u2013377 (2020).","journal-title":"J. Pathol."},{"key":"74545_CR55","doi-asserted-by":"publisher","first-page":"e0238546","DOI":"10.1371\/journal.pone.0238546","volume":"15","author":"J Ballesteros-\u00c1lvarez","year":"2020","unstructured":"Ballesteros-\u00c1lvarez, J. et al. MITF and TFEB cross-regulation in melanoma cells. PloS one 15, e0238546 (2020).","journal-title":"PloS one"},{"key":"74545_CR56","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.molcel.2022.12.013","volume":"83","author":"C Nardone","year":"2023","unstructured":"Nardone, C. et al. A central role for regulated protein stability in the control of TFE3 and MITF by nutrients. Mol. cell 83, 57\u201373.e59 (2023).","journal-title":"Mol. cell"},{"key":"74545_CR57","doi-asserted-by":"publisher","first-page":"e1008039","DOI":"10.1371\/journal.pgen.1008039","volume":"15","author":"F Oppel","year":"2019","unstructured":"Oppel, F. et al. Loss of ATRX cooperates with p53-deficiency to promote the development of sarcomas and other malignancies. PLoS Genet. 15, e1008039 (2019).","journal-title":"PLoS Genet."},{"key":"74545_CR58","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.pharmthera.2019.06.010","volume":"202","author":"E Thoenen","year":"2019","unstructured":"Thoenen, E., Curl, A. & Iwakuma, T. TP53 in bone and soft tissue sarcomas. Pharmacol. Ther. 202, 149\u2013164 (2019).","journal-title":"Pharmacol. Ther."},{"key":"74545_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30496-0","volume":"13","author":"MM Gounder","year":"2022","unstructured":"Gounder, M. M. et al. Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma. Nat. Commun. 13, 3406 (2022).","journal-title":"Nat. Commun."},{"key":"74545_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30453-x","volume":"13","author":"BA Nacev","year":"2022","unstructured":"Nacev, B. A. et al. Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets. Nat. Commun. 13, 3405 (2022).","journal-title":"Nat. Commun."},{"key":"74545_CR61","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1016\/j.ejca.2015.04.023","volume":"51","author":"S Croce","year":"2015","unstructured":"Croce, S. & Chibon, F. MED12 and uterine smooth muscle oncogenesis: State of the art and perspectives. Eur. J. Cancer 51, 1603\u20131610 (2015).","journal-title":"Eur. J. Cancer"},{"key":"74545_CR62","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.devcel.2015.01.026","volume":"32","author":"A Thien","year":"2015","unstructured":"Thien, A. et al. TSC1 activates TGF-\u03b2-Smad2\/3 signaling in growth arrest and epithelial-to-mesenchymal transition. Dev. Cell 32, 617\u2013630 (2015).","journal-title":"Dev. Cell"},{"key":"74545_CR63","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1053\/hupa.2002.31475","volume":"33","author":"G Amir","year":"2002","unstructured":"Amir, G. et al. Expression of p53 gene product and cell proliferation marker Ki-67 in Ewing\u2019s sarcoma: correlation with clinical outcome. Hum. Pathol. 33, 170\u2013174 (2002).","journal-title":"Hum. Pathol."},{"key":"74545_CR64","doi-asserted-by":"publisher","first-page":"17635","DOI":"10.1007\/s00432-023-05441-3","volume":"149","author":"N Banaszek","year":"2023","unstructured":"Banaszek, N., Kurpiewska, D., Kozak, K., Rutkowski, P. & Sobczuk, P. Hedgehog pathway in sarcoma: from preclinical mechanism to clinical application. J. Cancer Res. Clin. Oncol. 149, 17635\u201317649 (2023).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"74545_CR65","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/5952836","volume":"2019","author":"Z Liu","year":"2019","unstructured":"Liu, Z. et al. TP53 mutations promote immunogenic activity in breast cancer. J. Oncol. 2019, 5952836 (2019).","journal-title":"J. Oncol."},{"key":"74545_CR66","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1038\/s41419-022-05408-1","volume":"13","author":"X Chen","year":"2022","unstructured":"Chen, X. et al. Mutant p53 in cancer: from molecular mechanism to therapeutic modulation. Cell Death Dis. 13, 974 (2022).","journal-title":"Cell Death Dis."},{"key":"74545_CR67","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13045-023-01464-y","volume":"16","author":"CM Rudin","year":"2023","unstructured":"Rudin, C. M. et al. Emerging therapies targeting the delta-like ligand 3 (DLL3) in small cell lung cancer. J. Hematol. Oncol. 16, 66 (2023).","journal-title":"J. Hematol. Oncol."},{"key":"74545_CR68","doi-asserted-by":"publisher","first-page":"5534","DOI":"10.1158\/1078-0432.CCR-20-1191","volume":"26","author":"R Sanfilippo","year":"2020","unstructured":"Sanfilippo, R. et al. Addition of antiestrogen treatment in patients with malignant PEComa progressing to mTOR inhibitors. Clin. Cancer Res 26, 5534\u20135538 (2020).","journal-title":"Clin. Cancer Res"},{"key":"74545_CR69","doi-asserted-by":"publisher","first-page":"14960","DOI":"10.1073\/pnas.1309110110","volume":"110","author":"X Gu","year":"2013","unstructured":"Gu, X. et al. Integration of mTOR and estrogen-ERK2 signaling in lymphangioleiomyomatosis pathogenesis. Proc. Natl. Acad. Sci. USA 110, 14960\u201314965 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"74545_CR70","doi-asserted-by":"publisher","unstructured":"Patel, P. G. et al. Preparation of Formalin-fixed Paraffin-embedded Tissue Cores for both RNA and DNA Extraction. J. Vis. Exp. https:\/\/doi.org\/10.3791\/54299 (2016).","DOI":"10.3791\/54299"},{"key":"74545_CR71","doi-asserted-by":"publisher","unstructured":"Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J. https:\/\/doi.org\/10.14806\/ej.17.1.200 (2011).","DOI":"10.14806\/ej.17.1.200"},{"key":"74545_CR72","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357\u2013359 (2012).","journal-title":"Nat. Methods"},{"key":"74545_CR73","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinforma 29, 15\u201321 (2013).","journal-title":"Bioinforma"},{"key":"74545_CR74","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","volume":"31","author":"S Anders","year":"2014","unstructured":"Anders, S., Pyl, P. T. & Huber, W. HTSeq\u2014a Python framework to work with high-throughput sequencing data. Bioinforma 31, 166\u2013169 (2014).","journal-title":"Bioinforma"},{"key":"74545_CR75","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s12064-012-0162-3","volume":"131","author":"GP Wagner","year":"2012","unstructured":"Wagner, G. P., Kin, K. & Lynch, V. J. Measurement of mRNA abundance using RNA-seq data: RPKM measure is inconsistent among samples. Theory Biosci. 131, 281\u2013285 (2012).","journal-title":"Theory Biosci."},{"key":"74545_CR76","doi-asserted-by":"crossref","unstructured":"Haas BJ, Dobin A, Li B, Stransky N, Pochet N, Regev A. Accuracy assessment of fusion transcript detection via read-mapping and de novo fusion transcript assembly-based methods. Genome Biol. 20, 213 (2019).","DOI":"10.1186\/s13059-019-1842-9"},{"key":"74545_CR77","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1093\/nar\/gkw032","volume":"44","author":"M Babiceanu","year":"2016","unstructured":"Babiceanu, M. et al. Recurrent chimeric fusion RNAs in non-cancer tissues and cells. Nucleic Acids Res. 44, 2859\u20132872 (2016).","journal-title":"Nucleic Acids Res."},{"key":"74545_CR78","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows\u2013Wheeler transform. Bioinforma 25, 1754\u20131760 (2009).","journal-title":"Bioinforma"},{"key":"74545_CR79","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1101\/gr.129684.111","volume":"22","author":"DC Koboldt","year":"2012","unstructured":"Koboldt, D. C. et al. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 22, 568\u2013576 (2012).","journal-title":"Genome Res."},{"key":"74545_CR80","doi-asserted-by":"publisher","first-page":"D733","DOI":"10.1093\/nar\/gkv1189","volume":"44","author":"NA O\u2019Leary","year":"2016","unstructured":"O\u2019Leary, N. A. et al. Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation. Nucleic acids Res. 44, D733\u2013D745 (2016).","journal-title":"Nucleic acids Res."},{"key":"74545_CR81","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1093\/nar\/29.1.308","volume":"29","author":"ST Sherry","year":"2001","unstructured":"Sherry, S. T. et al. dbSNP: the NCBI database of genetic variation. Nucleic acids Res. 29, 308\u2013311 (2001).","journal-title":"Nucleic acids Res."},{"key":"74545_CR82","doi-asserted-by":"publisher","first-page":"D941","DOI":"10.1093\/nar\/gky1015","volume":"47","author":"JG Tate","year":"2018","unstructured":"Tate, J. G. et al. COSMIC: the catalogue of somatic mutations in cancer. Nucleic acids Res. 47, D941\u2013D947 (2018).","journal-title":"Nucleic acids Res."},{"key":"74545_CR83","doi-asserted-by":"publisher","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","volume":"46","author":"MJ Landrum","year":"2018","unstructured":"Landrum, M. J. et al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic acids Res. 46, D1062\u2013d1067 (2018).","journal-title":"Nucleic acids Res."},{"key":"74545_CR84","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-0974-4","volume":"17","author":"W McLaren","year":"2016","unstructured":"McLaren, W. et al. The ensembl variant effect predictor. Genome Biol. 17, 122 (2016).","journal-title":"Genome Biol."},{"key":"74545_CR85","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1158\/2159-8290.CD-17-0151","volume":"7","author":"AACR Project GENIE","year":"2017","unstructured":"AACR Project GENIE Powering precision medicine through an international consortium. Cancer Discov. 7, 818\u2013831 (2017).","journal-title":"Cancer Discov."},{"key":"74545_CR86","first-page":"3982","volume":"33","author":"Y Tian","year":"2017","unstructured":"Tian, Y. et al. ChAMP: updated methylation analysis pipeline for Illumina BeadChips. Bioinforma. (Oxf., Engl.) 33, 3982\u20133984 (2017).","journal-title":"Bioinforma. (Oxf., Engl.)"},{"key":"74545_CR87","first-page":"e22","volume":"45","author":"W Zhou","year":"2017","unstructured":"Zhou, W., Laird, P. W. & Shen, H. Comprehensive characterization, annotation and innovative use of Infinium DNA methylation BeadChip probes. Nucleic acids Res. 45, e22 (2017).","journal-title":"Nucleic acids Res."},{"key":"74545_CR88","doi-asserted-by":"publisher","unstructured":"Lu, X. et al. Racial disparities in MiT family translocation renal cell carcinoma. Oncologist https:\/\/doi.org\/10.1093\/oncolo\/oyad173 (2023).","DOI":"10.1093\/oncolo\/oyad173"},{"key":"74545_CR89","doi-asserted-by":"publisher","first-page":"4129","DOI":"10.1158\/1078-0432.CCR-13-3036","volume":"20","author":"GG Malouf","year":"2014","unstructured":"Malouf, G. G. et al. Next-generation sequencing of translocation renal cell carcinoma reveals novel RNA splicing partners and frequent mutations of chromatin-remodeling genes. Clin. Cancer Res. 20, 4129\u20134140 (2014).","journal-title":"Clin. Cancer Res."},{"key":"74545_CR90","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.ccell.2018.03.007","volume":"33","author":"AM Taylor","year":"2018","unstructured":"Taylor, A. M. et al. Genomic and functional approaches to understanding cancer aneuploidy. Cancer cell 33, 676\u2013689.e673 (2018).","journal-title":"Cancer cell"},{"key":"74545_CR91","doi-asserted-by":"publisher","DOI":"10.1002\/imt2.43","volume":"1","author":"Z Gu","year":"2022","unstructured":"Gu, Z. Complex heatmap visualization. iMeta 1, e43 (2022).","journal-title":"iMeta"},{"key":"74545_CR92","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-58766-1","volume":"10","author":"CR John","year":"2020","unstructured":"John, C. R. et al. M3C: Monte Carlo reference-based consensus clustering. Sci. Rep. 10, 1816 (2020).","journal-title":"Sci. Rep."},{"key":"74545_CR93","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-16747-x","volume":"7","author":"PW Eide","year":"2017","unstructured":"Eide, P. W., Bruun, J., Lothe, R. A. & Sveen, A. CMScaller: an R package for consensus molecular subtyping of colorectal cancer pre-clinical models. Sci. Rep. 7, 16618 (2017).","journal-title":"Sci. Rep."},{"key":"74545_CR94","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic acids Res. 43, e47\u2013e47 (2015).","journal-title":"Nucleic acids Res."},{"key":"74545_CR95","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1606","volume":"14","author":"J Zhu","year":"2024","unstructured":"Zhu, J. et al. MOVICShiny: an interactive website for multi-omics integration and visualisation in cancer subtyping. Clin. Transl. Med. 14, e1606 (2024).","journal-title":"Clin. Transl. Med."},{"key":"74545_CR96","first-page":"5539","volume":"36","author":"X Lu","year":"2021","unstructured":"Lu, X., Meng, J., Zhou, Y., Jiang, L. & Yan, F. MOVICS: an R package for multi-omics integration and visualization in cancer subtyping. Bioinforma. (Oxf., Engl.) 36, 5539\u20135541 (2021).","journal-title":"Bioinforma. (Oxf., Engl.)"},{"key":"74545_CR97","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu, T. et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innov. (N. Y., N. Y) 2, 100141 (2021).","journal-title":"Innov. (N. Y., N. Y)"},{"key":"74545_CR98","doi-asserted-by":"publisher","DOI":"10.1002\/cpz1.90","volume":"1","author":"Z Xie","year":"2021","unstructured":"Xie, Z. et al. Gene set knowledge discovery with enrichr. Curr. Protoc. 1, e90 (2021).","journal-title":"Curr. Protoc."},{"key":"74545_CR99","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.immuni.2022.02.001","volume":"55","author":"M Meylan","year":"2022","unstructured":"Meylan, M. et al. Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer. Immunity 55, 527\u2013541.e525 (2022).","journal-title":"Immunity"},{"key":"74545_CR100","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.cell.2018.03.034","volume":"173","author":"TM Malta","year":"2018","unstructured":"Malta, T. M. et al. Machine learning identifies stemness features associated with oncogenic dedifferentiation. Cell 173, 338\u2013354.e315 (2018).","journal-title":"Cell"},{"key":"74545_CR101","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34268-8","volume":"13","author":"JL Endicott","year":"2022","unstructured":"Endicott, J. L., Nolte, P. A., Shen, H. & Laird, P. W. Cell division drives DNA methylation loss in late-replicating domains in primary human cells. Nat. Commun. 13, 6659 (2022).","journal-title":"Nat. Commun."},{"key":"74545_CR102","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1093\/bioinformatics\/bty902","volume":"35","author":"TC Silva","year":"2018","unstructured":"Silva, T. C. et al. ELMER v.2: an R\/Bioconductor package to reconstruct gene regulatory networks from DNA methylation and transcriptome profiles. Bioinforma 35, 1974\u20131977 (2018).","journal-title":"Bioinforma"},{"key":"74545_CR103","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.molcel.2010.05.004","volume":"38","author":"S Heinz","year":"2010","unstructured":"Heinz, S. et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 38, 576\u2013589 (2010).","journal-title":"Mol. Cell"},{"key":"74545_CR104","doi-asserted-by":"publisher","first-page":"D116","DOI":"10.1093\/nar\/gkv1249","volume":"44","author":"IV Kulakovskiy","year":"2016","unstructured":"Kulakovskiy, I. V. et al. HOCOMOCO: expansion and enhancement of the collection of transcription factor binding sites models. Nucleic acids Res. 44, D116\u2013D125 (2016).","journal-title":"Nucleic acids Res."},{"key":"74545_CR105","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-015-0668-3","volume":"16","author":"L Yao","year":"2015","unstructured":"Yao, L., Shen, H., Laird, P. W., Farnham, P. J. & Berman, B. P. Inferring regulatory element landscapes and transcription factor networks from cancer methylomes. Genome Biol. 16, 105 (2015).","journal-title":"Genome Biol."},{"key":"74545_CR106","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2013","unstructured":"Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general-purpose program for assigning sequence reads to genomic features. Bioinforma 30, 923\u2013930 (2013).","journal-title":"Bioinforma"},{"key":"74545_CR107","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573\u20133587.e3529 (2021).","journal-title":"Cell"},{"key":"74545_CR108","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1038\/s41592-023-01943-7","volume":"20","author":"SJ Fleming","year":"2023","unstructured":"Fleming, S. J. et al. Unsupervised removal of systematic background noise from droplet-based single-cell experiments using CellBender. Nat. Methods 20, 1323\u20131335 (2023).","journal-title":"Nat. Methods"},{"key":"74545_CR109","doi-asserted-by":"publisher","unstructured":"Lu, X. et al. Molecular taxonomy of pancreatic neuroendocrine tumors reveals <em>BEND2<\/em>-fusions-driven transcriptional plasticity and therapeutic vulnerabilities. Cell Rep. Med. 7, https:\/\/doi.org\/10.1016\/j.xcrm.2026.102642 (2026).","DOI":"10.1016\/j.xcrm.2026.102642"},{"key":"74545_CR110","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1016\/j.celrep.2019.09.082","volume":"29","author":"EAK DePasquale","year":"2019","unstructured":"DePasquale, E. A. K. et al. DoubletDecon: Deconvoluting Doublets from Single-Cell RNA-Sequencing Data. Cell Rep. 29, 1718\u20131727.e1718 (2019).","journal-title":"Cell Rep."},{"key":"74545_CR111","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.cels.2019.03.003","volume":"8","author":"CS McGinnis","year":"2019","unstructured":"McGinnis, C. S., Murrow, L. M. & Gartner, Z. J. DoubletFinder: doublet detection in single-cell RNA sequencing data using artificial nearest neighbors. Cell Syst. 8, 329\u2013337.e324 (2019).","journal-title":"Cell Syst."},{"key":"74545_CR112","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.jcmgh.2022.10.001","volume":"15","author":"YJ Zhou","year":"2023","unstructured":"Zhou, Y. J. et al. Single-cell transcriptomics reveals early molecular and immune alterations underlying the serrated neoplasia pathway toward colorectal cancer. Cell. Mol. Gastroenterol. Hepatol. 15, 393\u2013424 (2023).","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"74545_CR113","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.cmet.2022.05.010","volume":"34","author":"H Wu","year":"2022","unstructured":"Wu, H. et al. Mapping the single-cell transcriptomic response of murine diabetic kidney disease to therapies. Cell Metab. 34, 1064\u20131078.e1066 (2022).","journal-title":"Cell Metab."},{"key":"74545_CR114","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1126\/science.1254257","volume":"344","author":"AP Patel","year":"2014","unstructured":"Patel, A. P. et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science 344, 1396\u20131401 (2014).","journal-title":"Science"},{"key":"74545_CR115","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin, S. et al. Inference and analysis of cell-cell communication using CellChat. Nat. Commun. 12, 1088 (2021).","journal-title":"Nat. Commun."},{"key":"74545_CR116","doi-asserted-by":"publisher","DOI":"10.1002\/imm3.70005","volume":"1","author":"X Lu","year":"2025","unstructured":"Lu, X. et al. FigureYa: a standardized visualization framework for enhancing biomedical data interpretation and research efficiency. iMetaMed 1, e70005 (2025).","journal-title":"iMetaMed"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74545-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74545-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74545-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T11:03:57Z","timestamp":1786014237000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74545-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":116,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["74545"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-74545-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"28 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"GM reports consulting activities with MSD, Ipsen, and BMS, and a research grant from MSD AVENIR. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"7872"}}